Table 5. Characteristics of individual studies included in the meta-analysis.

Study	Ethnic	Age		Gender		Populations		Methods
		Responsive	Resistant	Responsive (M/F)	Resistant (M/F)	Drugs responsive	Drugs resistant
Angelopoulou et al. [29]	Greece	40.76 ± 16.55	43.56 ± 16.37	62/68	37/33	130	70	TaqMan assay
Boting Zhou et al. [28]	Chinese	N/A	N/A	N/A	N/A	N/A	N/A	Illumina Sequencing
Luo Zhou et al. [30]	Chinese	22.36 ± 14.10	22.98 ± 11.21	144/91	103/53	235	156	Illumina Sequencing
Patrick Kwana et al. [31]	Chinese (Hongkong)	N/A	N/A	N/A	N/A	272	199	RT-PCR
Yuze Cao et al. [32]	Chinese	18.2 ± 16.8	19.0 ± 9.8	162	136	273	207	Illumina Sequencing
Blanca et al. [23]	Spainish	26.0 ± 19.8	27.0 ± 18.5	88/90	56/55	178	111	TaqMan assay
R. Kumari et al [33]	India	N/A	N/A	N/A	N/A	124	89	Real Time PCR
Ida Manna et al. [34]	Italy	N/A	N/A	N/A	N/A	401	482	Real Time PCR
Wang et al.	Chinese	9.13 + 4.01	7.79 + 4.01	144/85	38/22	229	60	MassArray
Haerian BS et al. [35]	Malay	28 ± 15	30 ± 15	70/56	64/61	126	125	MassArra
Haerian BS et al. [30]	India	30 ± 16	33 ± 17	49/43	38/32	92	70	MassArra
Haerian BS et al. [30]	Chinese	34 ± 19	33 ± 17	83/65	77/63	148	140	MassArra
Haerian BS et al. [30]	Chinese (HongKong)	38 ± 16	38 ± 14	180/156	225/242	336	467	MassArray